🔓 Unlock the full profile of Abidali Dossa (Transformance Forums), including verified contact details, financial insights, and professional associations.

See Abidali Dossa Full Profile

Below are the ✅ Verified Contact Details to help you connect directly:

Email: abi*****@tra******.com

Mobile: 76344*****

Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)

Key Insights You Should Know About This Individual

  • Abidali Dossa is the founder of Transformance Forums, established in March 2016, aimed at facilitating knowledge-sharing and transformative discussions across various sectors.
  • As a co-founder of UBS Transformance, Dossa contributed to the organization's initiatives from March 2016 until April 2018, focusing on enhancing collaboration and innovation in the financial sector.
  • From November 2008 to March 2016, Dossa acted as an independent consultant, providing leadership and strategic consulting for summits, conferences, and knowledge forums, emphasizing the importance of networking and knowledge exchange.
  • While at ITP from December 2010 until March 2012, Dossa served as Head of Knowledge Forums and Conferences, playing a key role in organizing events to disseminate knowledge and foster collaboration among professionals.
  • Dossa's experience includes directing aviation conferences at SMG from December 2006 to September 2008, contributing to the growth and engagement of that specific industry through targeted events.
  • As General Manager at Informedia India Pvt. Ltd. Co. from June 2005 to November 2006, Dossa was involved in operational leadership, impacting company performance and strategic direction.
  • From February 2000 to May 2005, Dossa held the position of Conference Director for India and the Middle East at Marcus Evans, significantly impacting the conference landscape in those regions.
  • Earlier in the career, Dossa was a Territory Manager at Eli Lilly and Company from January 1996 to January 1999, gaining valuable experience in territory management and client relations in the pharmaceutical industry.